Notice Number: NOT-HL-17-510
Key Dates
Release Date: April 27, 2017
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
The purpose of this Notice is to inform potential applicants of changes to the Key Dates for PAR-16-021 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)".
All other aspects of this FOA remain unchanged.
Currently reads:
Letter of Intent Due Date(s) |
30 days prior to the application due date |
Application Due Date(s) |
January 19, 2016; January 19, 2017; January 19, 2018; January 18, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
AIDS Application Due Date(s) |
Not Applicable |
Scientific Merit Review |
June 2016; June 2017; June 2018; and June 2019 |
Advisory Council Review |
Not Applicable |
Earliest Start Date |
September 2016; September 2017; September 2018; September 2019 |
Expiration Date |
January 19, 2019 |
Due Dates for E.O. 12372 |
Not Applicable |
Modified to read:
Letter of Intent Due Date(s) |
30 days prior to the application due date |
Application Due Date(s) |
January 19, 2016; January 19, 2017; October 19, 2017; October 18, 2018 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
AIDS Application Due Date(s) |
Not Applicable |
Scientific Merit Review |
June 2016; June 2017; March 2018; and March 2019 |
Advisory Council Review |
Not Applicable |
Earliest Start Date |
September 2016; September 2017; July 2018; July 2019 |
Expiration Date |
October 19, 2018 |
Due Dates for E.O. 12372 |
Not Applicable |
Inquiries
Please direct all inquiries to:
Weiniu Gan, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0202
Email: ganw2@mail.nih.gov